Mirum Pharmaceuticals Inc (MIRM) Stock Analysis

Mirum Pharmaceuticals Inc (MIRM) is a publicly traded company in the HEALTHCARE sector. It trades at $92.17, carries a market capitalization of $5.87B. This page summarizes the public market data, fundamentals, and frequently asked questions for MIRM, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Mirum Pharmaceuticals Inc currently has a Bullish sentiment score of 0.23.

About Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals, Inc., headquartered in Foster City, California, is a biopharmaceutical company dedicated to developing innovative therapies for severe liver diseases. The company boasts a strong pipeline, featuring novel treatment candidates that target significant unmet medical needs in hepatology. With a clear focus on clinical development and a commitment to patient-centered care, Mirum presents a compelling opportunity for institutional investors seeking exposure to transformative ...

GNG Research Analysis

GNG Research scores Mirum Pharmaceuticals Inc (MIRM) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MIRM.

Frequently Asked Questions

Does MIRM pay dividends?

Mirum Pharmaceuticals Inc (MIRM) does not currently pay a regular dividend.

What is MIRM's market cap?

Mirum Pharmaceuticals Inc (MIRM) has a market capitalization of $5.87B with a current stock price of $92.17.